Natpar (parathyroid hormone): Discontinuation of manufacturing at the end of 2024 and update on 100mcg shortage

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Natpar
Active substance
parathyroid hormone
Therapeutic area (MeSH)
Hypoparathyroidism
Procedure number
EMEA/H/C/003861
Regulatory outcome
Maintenance
DHPC type
Medicine shortage
Human ATC code
H05AA03
Dissemination date
04/10/2022

How useful was this page?

Add your rating